Portal Investigación UEx

Tamaño De La Fontanela En El Recién Nacido Normal. Relación Con Parámetros Antropométricos Y Bioquímicos

Association Between Adherence To Patient Blood Management Recommendations And Postoperative Complications In Hip And Knee Arthroplasty

Prognostic Significance Of Mutation Type And Chromosome Fragility In Fanconi Anemia

Association Between Adherence To Patient Blood Management Recommendations And Postoperative Complications In Hip And Knee Arthroplasty

Prognostic Significance Of Mutation Type And Chromosome Fragility In Fanconi Anemia

Eltrombopag For Bone Marrow Failure In Fanconi Anemia: Results From The Phase Ii Clinical Trial Fancrev

Prognostic Significance Of Mutation Type And Chromosome Fragility In Fanconi Anemia

Eltrombopag For Bone Marrow Failure In Fanconi Anemia: Results From The Phase Ii Clinical Trial Fancrev

Haploidentical Vs. Hla-Matched Donor Hematopoietic Stem-Cell Transplantation For Pediatric Patients With Acute Lymphoblastic Leukemia In Second Remission: A Collaborative Retrospective Study Of The Spanish Group For Bone Marrow Transplantation In Children (Getmon/geth) And The Spanish Childhood Relapsed All Board (Reallnet)

Eltrombopag For Bone Marrow Failure In Fanconi Anemia: Results From The Phase Ii Clinical Trial Fancrev

Haploidentical Vs. Hla-Matched Donor Hematopoietic Stem-Cell Transplantation For Pediatric Patients With Acute Lymphoblastic Leukemia In Second Remission: A Collaborative Retrospective Study Of The Spanish Group For Bone Marrow Transplantation In Children (Getmon/geth) And The Spanish Childhood Relapsed All Board (Reallnet)

Adolescent Cancer Care: What Has Changed In Spain In The Past Decade?

Haploidentical Vs. Hla-Matched Donor Hematopoietic Stem-Cell Transplantation For Pediatric Patients With Acute Lymphoblastic Leukemia In Second Remission: A Collaborative Retrospective Study Of The Spanish Group For Bone Marrow Transplantation In Children (Getmon/geth) And The Spanish Childhood Relapsed All Board (Reallnet)

Adolescent Cancer Care: What Has Changed In Spain In The Past Decade?

Venous Thromboembolism In Pediatric Patients With Acute Lymphoblastic Leukemia Under Chemotherapy Treatment. Risk Factors And Usefulness Of Thromboprophylaxis. Results Of Lal-Sehop-Pethema-2013

Adolescent Cancer Care: What Has Changed In Spain In The Past Decade?

Venous Thromboembolism In Pediatric Patients With Acute Lymphoblastic Leukemia Under Chemotherapy Treatment. Risk Factors And Usefulness Of Thromboprophylaxis. Results Of Lal-Sehop-Pethema-2013

A New Case Of Acquired Haemophilia B In The Context Of Liver Autoimmune Disease

Venous Thromboembolism In Pediatric Patients With Acute Lymphoblastic Leukemia Under Chemotherapy Treatment. Risk Factors And Usefulness Of Thromboprophylaxis. Results Of Lal-Sehop-Pethema-2013

A New Case Of Acquired Haemophilia B In The Context Of Liver Autoimmune Disease

Phase 2 Clinical Trial Of Infusing Haploidentical K562-Mb15-41bbl–activated And Expanded Natural Killer Cells As Consolidation Therapy For Pediatric Acute Myeloblastic Leukemia

A New Case Of Acquired Haemophilia B In The Context Of Liver Autoimmune Disease

Phase 2 Clinical Trial Of Infusing Haploidentical K562-Mb15-41bbl–activated And Expanded Natural Killer Cells As Consolidation Therapy For Pediatric Acute Myeloblastic Leukemia

Measurable Residual Disease Assessed By Flow-Cytometry Is A Stable Prognostic Factor For Pediatric T-Cell Acute Lymphoblastic Leukemia In Consecutive Sehop Protocols Whereas The Impact Of Oncogenetics Depends On Treatment

Phase 2 Clinical Trial Of Infusing Haploidentical K562-Mb15-41bbl–activated And Expanded Natural Killer Cells As Consolidation Therapy For Pediatric Acute Myeloblastic Leukemia

Measurable Residual Disease Assessed By Flow-Cytometry Is A Stable Prognostic Factor For Pediatric T-Cell Acute Lymphoblastic Leukemia In Consecutive Sehop Protocols Whereas The Impact Of Oncogenetics Depends On Treatment

Study Protocol For A Phase Ii, Multicentre, Prospective, Non-Randomised Clinical Trial To Assess The Safety And Efficacy Of Infusing Allogeneic Activated And Expanded Natural Killer Cells As Consolidation Therapy For Paediatric Acute Myeloblastic Leukaemia

Measurable Residual Disease Assessed By Flow-Cytometry Is A Stable Prognostic Factor For Pediatric T-Cell Acute Lymphoblastic Leukemia In Consecutive Sehop Protocols Whereas The Impact Of Oncogenetics Depends On Treatment

Study Protocol For A Phase Ii, Multicentre, Prospective, Non-Randomised Clinical Trial To Assess The Safety And Efficacy Of Infusing Allogeneic Activated And Expanded Natural Killer Cells As Consolidation Therapy For Paediatric Acute Myeloblastic Leukaemia

Management Of Iron Deficiency In Various Clinical Conditions And The Role Of Intravenous Iron: Recommendations Of The Spanish Erythropathology Group Of The Spanish Society Of Haematology And Haemotherapy

Study Protocol For A Phase Ii, Multicentre, Prospective, Non-Randomised Clinical Trial To Assess The Safety And Efficacy Of Infusing Allogeneic Activated And Expanded Natural Killer Cells As Consolidation Therapy For Paediatric Acute Myeloblastic Leukaemia

Management Of Iron Deficiency In Various Clinical Conditions And The Role Of Intravenous Iron: Recommendations Of The Spanish Erythropathology Group Of The Spanish Society Of Haematology And Haemotherapy

Optimised Molecular Genetic Diagnostics Of Fanconi Anaemia By Whole Exome Sequencing And Functional Studies

Management Of Iron Deficiency In Various Clinical Conditions And The Role Of Intravenous Iron: Recommendations Of The Spanish Erythropathology Group Of The Spanish Society Of Haematology And Haemotherapy

Optimised Molecular Genetic Diagnostics Of Fanconi Anaemia By Whole Exome Sequencing And Functional Studies

C>a Substitution In Nt 46 Of The 3' Utr Region (The Α Complex Protected Region) Of The Alpha-1 Globin Gene: A Non-Deletional Mutation Or Polymorphism?

Optimised Molecular Genetic Diagnostics Of Fanconi Anaemia By Whole Exome Sequencing And Functional Studies

C>a Substitution In Nt 46 Of The 3' Utr Region (The Α Complex Protected Region) Of The Alpha-1 Globin Gene: A Non-Deletional Mutation Or Polymorphism?

Expanding The Clinical And Genetic Spectra Of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected And Unexpected Findings

C>a Substitution In Nt 46 Of The 3' Utr Region (The Α Complex Protected Region) Of The Alpha-1 Globin Gene: A Non-Deletional Mutation Or Polymorphism?

Expanding The Clinical And Genetic Spectra Of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected And Unexpected Findings

Burkitt-Like Lymphoma With 11q Aberration: A Germinal Center-Derived Lymphoma Genetically Unrelated To Burkitt Lymphoma

Expanding The Clinical And Genetic Spectra Of Primary Immunodeficiency-Related Disorders With Clinical Exome Sequencing: Expected And Unexpected Findings

Burkitt-Like Lymphoma With 11q Aberration: A Germinal Center-Derived Lymphoma Genetically Unrelated To Burkitt Lymphoma

Recomendaciones Para El Abordaje Del Déficit De Hierro: Papel Del Hierro Intravenoso

Burkitt-Like Lymphoma With 11q Aberration: A Germinal Center-Derived Lymphoma Genetically Unrelated To Burkitt Lymphoma

Recomendaciones Para El Abordaje Del Déficit De Hierro: Papel Del Hierro Intravenoso

Effect Of Polymorphisms In Transporter Genes On Dosing, Efficacy And Toxicity Of Maintenance Therapy In Children With Acute Lymphoblastic Leukemia

Recomendaciones Para El Abordaje Del Déficit De Hierro: Papel Del Hierro Intravenoso

Effect Of Polymorphisms In Transporter Genes On Dosing, Efficacy And Toxicity Of Maintenance Therapy In Children With Acute Lymphoblastic Leukemia

Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements In Pediatric Patients With Acute Lymphoblastic Leukemia On Maintenance Therapy

Effect Of Polymorphisms In Transporter Genes On Dosing, Efficacy And Toxicity Of Maintenance Therapy In Children With Acute Lymphoblastic Leukemia

Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements In Pediatric Patients With Acute Lymphoblastic Leukemia On Maintenance Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm

Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements In Pediatric Patients With Acute Lymphoblastic Leukemia On Maintenance Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm

Etiopathological Mechanisms And Clinical Characteristics Of Hyperhemolysis Syndrome In Spanish Patients With Thalassemia

Blastic Plasmacytoid Dendritic Cell Neoplasm

Etiopathological Mechanisms And Clinical Characteristics Of Hyperhemolysis Syndrome In Spanish Patients With Thalassemia

Congenital Dyserythropoietic Anemia Associated To A Gata1 Mutation Aggravated By Pyruvate Kinase Deficiency

Etiopathological Mechanisms And Clinical Characteristics Of Hyperhemolysis Syndrome In Spanish Patients With Thalassemia

Congenital Dyserythropoietic Anemia Associated To A Gata1 Mutation Aggravated By Pyruvate Kinase Deficiency

Functional Consequences Of Transferrin Receptor-2 Mutations Causing Hereditary Hemochromatosis Type 3

Congenital Dyserythropoietic Anemia Associated To A Gata1 Mutation Aggravated By Pyruvate Kinase Deficiency

Functional Consequences Of Transferrin Receptor-2 Mutations Causing Hereditary Hemochromatosis Type 3

Clinical Relevance Of Erythrocyte Ferritin In Microcytic Anemias

Functional Consequences Of Transferrin Receptor-2 Mutations Causing Hereditary Hemochromatosis Type 3

Clinical Relevance Of Erythrocyte Ferritin In Microcytic Anemias

Thalassemia Diagnosis In A Blood Donor From A Unique Trimorphic Red Blood Cell Population Observed In The Recipient

Clinical Relevance Of Erythrocyte Ferritin In Microcytic Anemias

Thalassemia Diagnosis In A Blood Donor From A Unique Trimorphic Red Blood Cell Population Observed In The Recipient

Hyperhaemolysis Syndrome Responsive To Splenectomy In A Patient With Δβ-Thalassaemia: A Discussion On Underlying Mechanisms

Thalassemia Diagnosis In A Blood Donor From A Unique Trimorphic Red Blood Cell Population Observed In The Recipient

Hyperhaemolysis Syndrome Responsive To Splenectomy In A Patient With Δβ-Thalassaemia: A Discussion On Underlying Mechanisms

Diagnostic And Therapeutic Challenges Of Primary Autoimmune Haemolytic Anaemia In Children

Hyperhaemolysis Syndrome Responsive To Splenectomy In A Patient With Δβ-Thalassaemia: A Discussion On Underlying Mechanisms

Diagnostic And Therapeutic Challenges Of Primary Autoimmune Haemolytic Anaemia In Children

Ethylenediaminetetraacetic Acid-Dependent Pseudomacrocytosis

Diagnostic And Therapeutic Challenges Of Primary Autoimmune Haemolytic Anaemia In Children

Ethylenediaminetetraacetic Acid-Dependent Pseudomacrocytosis

Diagnostic Utility Of Hfe Variants In Spanish Patients: Association With Hla Alleles And Role In Susceptibility To Acute Lymphoblastic Leukemia

Ethylenediaminetetraacetic Acid-Dependent Pseudomacrocytosis

Diagnostic Utility Of Hfe Variants In Spanish Patients: Association With Hla Alleles And Role In Susceptibility To Acute Lymphoblastic Leukemia

Impact Of Genetic Polymorphisms On Chemotherapy Toxicity In Childhood Acute Lymphoblastic Leukemia

Diagnostic Utility Of Hfe Variants In Spanish Patients: Association With Hla Alleles And Role In Susceptibility To Acute Lymphoblastic Leukemia

Impact Of Genetic Polymorphisms On Chemotherapy Toxicity In Childhood Acute Lymphoblastic Leukemia

Central Nervous System Chemotoxicity During Treatment Of Pediatric Acute Lymphoblastic Leukemia/lymphoma

Impact Of Genetic Polymorphisms On Chemotherapy Toxicity In Childhood Acute Lymphoblastic Leukemia

Central Nervous System Chemotoxicity During Treatment Of Pediatric Acute Lymphoblastic Leukemia/lymphoma

Methotrexate-Induced Subacute Neurotoxicity In A Child With Acute Lymphoblastic Leukemia Carrying Genetic Polymorphisms Related To Folate Homeostasis

Central Nervous System Chemotoxicity During Treatment Of Pediatric Acute Lymphoblastic Leukemia/lymphoma

Methotrexate-Induced Subacute Neurotoxicity In A Child With Acute Lymphoblastic Leukemia Carrying Genetic Polymorphisms Related To Folate Homeostasis

Chronic Haemolytic Anaemia Because Of Pyruvate Kinase (Pk) Deficiency In A Child Heterozygous For Haemoglobin S And No Clinical Features Of Sickle Cell Disease

Methotrexate-Induced Subacute Neurotoxicity In A Child With Acute Lymphoblastic Leukemia Carrying Genetic Polymorphisms Related To Folate Homeostasis

Chronic Haemolytic Anaemia Because Of Pyruvate Kinase (Pk) Deficiency In A Child Heterozygous For Haemoglobin S And No Clinical Features Of Sickle Cell Disease

Retinal Toxic Reactions Following Photopheresis

Chronic Haemolytic Anaemia Because Of Pyruvate Kinase (Pk) Deficiency In A Child Heterozygous For Haemoglobin S And No Clinical Features Of Sickle Cell Disease

Retinal Toxic Reactions Following Photopheresis

Infection Caused By Fusarium Species In Non-Neutropenic Oncological Patients [4]

Retinal Toxic Reactions Following Photopheresis

Infection Caused By Fusarium Species In Non-Neutropenic Oncological Patients [4]

Resolution Of Disseminated Fusariosis In A Child With Acute Leukemia Treated With Combined Antifungal Therapy: A Case Report

Infection Caused By Fusarium Species In Non-Neutropenic Oncological Patients [4]

Resolution Of Disseminated Fusariosis In A Child With Acute Leukemia Treated With Combined Antifungal Therapy: A Case Report

Fotoféresis: Nueva Terapia Inmunomoduladora Para Enfermedades Mediadas Por Linfocitos T.

Resolution Of Disseminated Fusariosis In A Child With Acute Leukemia Treated With Combined Antifungal Therapy: A Case Report

Fotoféresis: Nueva Terapia Inmunomoduladora Para Enfermedades Mediadas Por Linfocitos T.

Photopheresis: New Immunomodulatory Therapy For T-Lymphocyte Mediated Diseases

Fotoféresis: Nueva Terapia Inmunomoduladora Para Enfermedades Mediadas Por Linfocitos T.

Photopheresis: New Immunomodulatory Therapy For T-Lymphocyte Mediated Diseases

Aplastic Anemia During Treatment With Albendazole [8]

Photopheresis: New Immunomodulatory Therapy For T-Lymphocyte Mediated Diseases

Aplastic Anemia During Treatment With Albendazole [8]

Changes In Platelet Count: A Primary Or Secondary Effect Of Rhu-Epo Therapy?

Aplastic Anemia During Treatment With Albendazole [8]

Changes In Platelet Count: A Primary Or Secondary Effect Of Rhu-Epo Therapy?

Assessment Of Iron Status By Erythrocyte Ferritin In Uremic Patients With Or Without Recombinant Human Erythropoietin Therapy

Changes In Platelet Count: A Primary Or Secondary Effect Of Rhu-Epo Therapy?

Assessment Of Iron Status By Erythrocyte Ferritin In Uremic Patients With Or Without Recombinant Human Erythropoietin Therapy

Tamaño De La Fontanela En El Recién Nacido Normal. Relación Con Parámetros Antropométricos Y Bioquímicos

Assessment Of Iron Status By Erythrocyte Ferritin In Uremic Patients With Or Without Recombinant Human Erythropoietin Therapy

Tamaño De La Fontanela En El Recién Nacido Normal. Relación Con Parámetros Antropométricos Y Bioquímicos

Association Between Adherence To Patient Blood Management Recommendations And Postoperative Complications In Hip And Knee Arthroplasty